Table 4.
Author Ref. | Article Type | All CHDs or Any CHD Subtypes | Study Limitations |
---|---|---|---|
Nieuwenhuijsen et al. [46] | Meta-analysis | Trihalomethanes: All CHDs: OR 17% (95% CI: 3, 34) VSDs: OR 58% (95% CI: 21, 107) |
Small number of studies. Differences in exposure measurement and cut-off points. |
Grazuleviciene et al. [47] | Cohort study | All CHDs: Brominated trihalomethanes: No dose response relationship. Bromodichloromethane exposure during first month of gestation: OR 2.16 (95% CI: 1.05, 4.46). |
Subjects were interviewed on water usage in last trimester, not first month, possibly leading to recall bias. |
Abbreviations: VSD: Ventricular septal defect.